⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm
businesswire.com
BIIB
IgE Receptor Antagonists Clinical Trial Pipeline Analysis: 12+ Key Companies Shaping the Future of IgE Receptor Antagonists Therapeutics | DelveInsight
globenewswire.com
AMRX
ARX
GSK
AZN
SNY
NVS
MRK
REGN
JNJ
PFE
BMY
LLY
VRTX
AMGN
ABBV
GILD
BIIB
CSL
AQST
RAPT
ALGT
Genovyn Appoints Industry Veterans Sammy Bell as Chief Scientific Officer and Jim Edinger as Chief Development Officer to Accelerate AI-Enabled Therapeutic Discovery and Development
globenewswire.com
BIIB
PFE
Happening Next Week! C-Level Technology Leadership and the Rise of Iconic Leaders Will Shape the Conversation at HMG Strategy’s 2026 New York CISO Summit. Be a Part of It. Register Now.
globenewswire.com
MSFT
PFE
BAC
CVS
FMS
DGX
VRTX
CMCSA
LAB
AMZN
GOOGL
NVDA
IBM
ORCL
AMD
INTC
META
ADBE
CRM
CSCO
ACN
TMO
UNH
JNJ
PG
XOM
CVX
KO
PEP
DIS
NFLX
TSLA
REGN
GILD
AMGN
BMY
MRNA
BIIB
CRSP
ROKU
DDOG
SNOW
PANW
ZS
CRWD
SMCI
ASML
QCOM
AMAT
MU
LRCX
KLAC
NXPI
ON
ADI
TXN
MCHP
AVGO
MRVL
PLTR
UPST
COIN
SOFI
PLUG
FCEL
SPCE
GOOG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
prnewswire.com
BIIB
FNIH Names Recipients of the 2026 Charles A. Sanders, MD, Partnership Award
businesswire.com
BIIB
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
globenewswire.com
BIIB
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
globenewswire.com
BIIB
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
accessnewswire.com
BIIB
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses
globenewswire.com
BIIB